Labcorp announces retirement of board member Dr. D. Gary Gilliland

LABCORP HOLDINGS INC.

Dr. Gilliland will retire from the Labcorp board effective December 31, 2025.
He served on the board since 2014 and was on the Audit Committee and Quality and Compliance Committee.
Gilliland is President and Director Emeritus of Fred Hutchinson Cancer Center, former Merck SVP.
Board thanked him for over 10 years of service; no replacement named yet.

item 5.02 item 7.01 item 9.01

LABCORP HOLDINGS INC. filing history →

Source: SEC EDGAR

accession 0000920148-25-000120

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.